NRC HEALTH (NRC) research
NRC HEALTH- Sector
- Healthcare
- Industry
- Health Information Services
- Last price
- $20.56
- As of
NRC HEALTH (NRC): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-11.
As of . Source: SEC EDGAR filings for NRC. Method and limitations.
Share the NRC intelligence card
See NRC live in the terminal
Track NRC's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live NRC terminal, freeActive signals for NRC
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +514% to NRC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +514% to NRC (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +514% to NRC (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 119.2%, EPS $0.31 vs $0.1414 estimate
- mediumEARNINGS_BEAT
Q2-2019: Beat consensus by 10.4% - EPS $0.29 vs $0.2626 estimate
FREE, NO ACCOUNT
Every signal on NRC, as it fires
New filings, 13F moves and cross asset signals on NRC land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in NRC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 637372202 · 2026Q2 | $7M | 0.01% | , |
| CITADEL ADVISORS LLCCUSIP 637372202 · 2026Q2 | $1.4M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 637372202 · 2026Q2 | $1.4M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, NRC
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
NRC against its peers
NRC's operating margin of 16.4% ranks in the 92nd percentile of 18 Health Information Services sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-31.
| Metric | NRC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 137M USD | 185M USD | 45 | 18 |
| Gross margin | n/a | 67.3% | n/a | 12 |
| Operating margin | 16.4% | -15.8% | 92 | 18 |
| Net margin | 8.4% | -25.7% | 87 | 18 |
| Return on equity | 82.9% | -29.2% | 97 | 18 |
| P / E | 0.4x | 27.0x | 6 | 7 |
Peers (20): CARL, TBRG, WEAV, PHR, SOPH, SY, AMWL, LFMD, SDGR, OPRX, HCAT, CCLD, RVRC, DRIO, VASO, HTFL, ONMD, HQY, CRVW, BEAT. Left out: HYDTF (no annual filing), RNLXY (period gap), DGNOF (no annual filing), VRHI (no annual filing), RMHI (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-01-31. Every figure is one full fiscal year read from one annual filing (NRC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more NRC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NRCand get the insider, 13F, options, and confluence read in one view.